what not to take with retatrutide UK 2026: Phase 3 Results Retatrutide vs Tirzepatide (2026): Differences

Progress & body metric tools to help you measure your progress over time

Wellness Plus members pay $69 per month for membership, reducing annual totals by $120

NEVER, EVER SHAKE THE VIAL

More research will be conducted to see if all GLP-1 drugs carry a similar risk of blood clots and DVT

Last reviewed: June 30, 2026 Last updated: June 30, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

Other companion solution providers should monitor progress of these solutions closely and adopt